AU2002212774A1 - Saururus chinensis extract for prevention and treatment of neurodegenerative disease - Google Patents

Saururus chinensis extract for prevention and treatment of neurodegenerative disease

Info

Publication number
AU2002212774A1
AU2002212774A1 AU2002212774A AU1277402A AU2002212774A1 AU 2002212774 A1 AU2002212774 A1 AU 2002212774A1 AU 2002212774 A AU2002212774 A AU 2002212774A AU 1277402 A AU1277402 A AU 1277402A AU 2002212774 A1 AU2002212774 A1 AU 2002212774A1
Authority
AU
Australia
Prior art keywords
prevention
treatment
chinensis extract
neurodegenerative disease
saururus chinensis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002212774A
Inventor
So-Ra Kim
Young-Joong Kim
Sang-Hyun Sung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elcom Bio Technology Co Ltd
Original Assignee
Elcom Bio Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR10-2000-0061688A external-priority patent/KR100446090B1/en
Priority claimed from KR10-2000-0061687A external-priority patent/KR100446089B1/en
Application filed by Elcom Bio Technology Co Ltd filed Critical Elcom Bio Technology Co Ltd
Publication of AU2002212774A1 publication Critical patent/AU2002212774A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)

Abstract

The present invention relates to Saururus chinensis extract for prevention and treatment of neurodegenerative disease and pharmaceutical preparations containing Saururs chinensis extract or an aristolactam alkaloid derivative separated therefrom.
AU2002212774A 2000-10-19 2001-10-19 Saururus chinensis extract for prevention and treatment of neurodegenerative disease Abandoned AU2002212774A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR0061688 2000-10-19
KR10-2000-0061688A KR100446090B1 (en) 2000-10-19 2000-10-19 Pharmaceutical preparations containing an saurolactam alkaloid derivative for prevention and treatment of neurodegenerative disease
KR0061687 2000-10-19
KR10-2000-0061687A KR100446089B1 (en) 2000-10-19 2000-10-19 Saururus chinensis extract for prevention and treatment of neurodegenerative disease and pharmaceutical preparations containing the same
PCT/KR2001/001766 WO2002032443A1 (en) 2000-10-19 2001-10-19 Saururus chinensis extract for prevention and treatment of neurodegenerative disease

Publications (1)

Publication Number Publication Date
AU2002212774A1 true AU2002212774A1 (en) 2002-04-29

Family

ID=26638479

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002212774A Abandoned AU2002212774A1 (en) 2000-10-19 2001-10-19 Saururus chinensis extract for prevention and treatment of neurodegenerative disease

Country Status (8)

Country Link
US (1) US20030045564A1 (en)
EP (1) EP1326623B1 (en)
JP (1) JP4157767B2 (en)
CN (1) CN1245983C (en)
AT (1) ATE360431T1 (en)
AU (1) AU2002212774A1 (en)
DE (1) DE60128120T2 (en)
WO (1) WO2002032443A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080260873A1 (en) * 2007-04-23 2008-10-23 Fancl Corporation Agent for prevention or improvement of neuropathy comprising pre-germinated brown rice lipid fraction as an effective ingredient
KR101124350B1 (en) * 2007-10-17 2012-03-15 한국화학연구원 Phenanthrene lactam derivatives having anticancer activity, method for preparing same and pharmaceutical composition containing same
WO2018111050A1 (en) * 2016-12-15 2018-06-21 한국생명공학연구원 Pharmaceutical composition comprising phenanthrene-lactam-based compound as effective ingredient for preventing or treating dyrk-related disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619943A (en) * 1981-06-04 1986-10-28 Rao Koppaka V Neolignans of Saururus cernuus L and analogues thereof
US4782077A (en) * 1987-08-20 1988-11-01 Monoclonetics International, Inc. Taliscanin and other aristolactams for treating neurological disorders, Parkinson's disease, Alzheimer disease and impotence
JP4014177B2 (en) * 1997-03-10 2007-11-28 株式会社資生堂 Protease inhibitor
KR100380634B1 (en) * 2000-10-19 2003-04-26 주식회사 엘컴사이언스 Composition containing a dibenzocyclooctane lignan derivative for prevention or treatment of neurodegenerative disease

Also Published As

Publication number Publication date
JP2004511525A (en) 2004-04-15
ATE360431T1 (en) 2007-05-15
EP1326623A4 (en) 2004-06-09
CN1394143A (en) 2003-01-29
JP4157767B2 (en) 2008-10-01
DE60128120T2 (en) 2008-01-10
DE60128120D1 (en) 2007-06-06
EP1326623A1 (en) 2003-07-16
EP1326623B1 (en) 2007-04-25
US20030045564A1 (en) 2003-03-06
CN1245983C (en) 2006-03-22
WO2002032443A1 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
WO2001062223A3 (en) Cosmetic preparations containing plant extracts
AU3652102A (en) Compounds and their uses
IL162214A (en) Pyridine derivatives and pharmaceutical compositions containing the same
MXPA02003596A (en) Novel pharmaceutical compositions of anti-tubercular drugs and process for their preparation.
DE60037020D1 (en) Anilinochinazoline als protein-tyrosin-kinasehemmer
MXPA05004247A (en) Chromones and chromone derivatives and uses thereof.
WO2002094774A3 (en) Oxcarbazepine dosage forms
AU2002217832A1 (en) Black tea extract for prevention of disease
IL153680A0 (en) Aplidine derivatives and methods for the preparation thereof
EP1391200A4 (en) Drug preparations
MY137435A (en) Retinoid compounds (i)
AU2002226030A1 (en) Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
AU2001265885A1 (en) Cosmetic and/or pharmaceutical preparations that contain an extract of the plant argania spinosa
WO2004033448A3 (en) Isolation, purification and synthesis of procyanidin b2 and uses thereof
PT1390008E (en) Pharmaceutical and cosmetic compositions comprising phospholipid complexes of vitis vinifera and of centella asiactica
AU6921300A (en) Novel glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
WO2005054222A3 (en) Flavonoid derivative
AU2002212774A1 (en) Saururus chinensis extract for prevention and treatment of neurodegenerative disease
AU2002342808A1 (en) Extract with anti-tumor and anti-poisonous activity
AU2670600A (en) Pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence
AU2002214336A1 (en) Pharmaceutical preparations containing a dibenzocyclooctane lignan derivative for prevention and treatment of neurodegenerative disease
AP2001002369A0 (en) Pharmaceutical complex.
AU2002310920A1 (en) Pharmaceutical compositions comprising ascomycin
AU2001262741A1 (en) Medicines for the prevention and treatment of neurodegenerative diseases